SCHEMBL5604151

SCHEMBL5604151

CCOCC(C)OCC(C)OC(=O)c1ccc(C(=O)O)cc1C(=O)OC(C)COC(C)COCC

nearest known ligand 0.39

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
MAPT P10636 2/20 0.38
TSHR P16473 2/20 0.38
MAPK1 P28482 1/20 0.38
ACE2 Q9BYF1 2/20 0.35
HRH3 Q9Y5N1 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HCAR3 P49019 1/20 0.34
KDM4E B2RXH2 2/20 0.33
LMNA P02545 1/20 0.33
CSNK2A2 P19784 1/20 0.33
CSNK2B P67870 1/20 0.33
CSNK2A1 P68400 1/20 0.33
CSNK2A3 Q8NEV1 1/20 0.33
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
HSD17B10 Q99714 1/20 0.33
PLA2G4B P0C869 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5603051 1.00 ALDH1A1 (0.39) ALDH1A1MAPTTSHRMAPK1ACE2
SCHEMBL5602707 0.83 ALDH1A1 (0.48) ALDH1A1TSHRMAPK1L3MBTL1KDM4E
SCHEMBL5603341 0.83 ALDH1A1 (0.48) ALDH1A1TSHRMAPK1L3MBTL1KDM4E
SCHEMBL17681473 0.77 ALDH1A1 (0.39) ALDH1A1MAPTTSHRMAPK1ACE2
SCHEMBL889774 0.77 ALDH1A1 (0.48) ALDH1A1MAPTTSHRMAPK1ACE2
SCHEMBL18083222 0.75 ALDH1A1 (0.41) ALDH1A1MAPTTSHRMAPK1ACE2
SCHEMBL9906968 0.74 ALDH1A1 (0.48) ALDH1A1TSHRL3MBTL1LMNA
SCHEMBL9940061 0.72 LMNA (0.50) ALDH1A1TSHRLMNA
SCHEMBL827667 0.72 TSHR (0.58) ALDH1A1TSHRMAPK1HRH3KDM4E
SCHEMBL19561857 0.72 MAPT (0.44) ALDH1A1MAPTTSHRACE2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1818361-B1 Preparing sterile articles from polymers containing a stabiliser based on a poly(oxyalkylene) OCCIDENTAL CHEM CO (US) 2013-07-24 EP disclosed
EP-1818361-A2 Preparing sterile articles from polymers containing a stabiliser based on a poly(oxyalkylene) OCCIDENTAL CHEMICAL CORPORATION (US) 2007-08-15 EP disclosed
EP-1313802-B1 PREPARING STERILE ARTICLES FROM POLYMERS CONTAINING A STABILISER BASED ON A POLY(OXYALKYLENE) OCCIDENTAL CHEM CO (US) 2007-06-20 EP disclosed
US-6451904-B1 DISCOLORATION INHIBITION OF POLYVINYL CHLORIDE WHEN EXPOSED TO IONIZING RADIATION OCCIDENTAL CHEMICAL CORPORATION 2002-09-17 US disclosed
US-20020055584-A1 Preparing sterile articles from polymers containing a stabilizer based on a poly (oxyalkylene) OCCIDENTAL CHEMICAL CORPORATION 2002-05-09 US disclosed
US-6348517-B1 HALOGEN CONTAINING POLYMERS WITH STABILIZERS FOR STERILE ARTICLES OXY SERVICES, INC. 2002-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020055584-A1 Preparing sterile articles from polymers containing a stabilizer based on a poly (oxyalkylene) SFN, XRCC6, SPOUT1 ALDH1A1 3954/4885MAPT 2495/4885TSHR 1248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.